Women Are Less Likely to Receive a Pump for Heart Failure

New technology makes the devices safer for men and women

Women are less likely than men to receive a mechanical heart pump that is becoming the norm for people with advanced heart failure, according to new research.

The study, published in the American Heart Association journal Circulation: Heart Failure, took a deeper look at long-standing differences in how women are treated for heart failure — a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen. Heart failure affects 6.5 million Americans, a number projected to rise to 9 million by 2030.

“We have to be more cognizant of the implicit bias that makes us choose different therapies for men and women.”

About 10% of people with heart failure have an advanced form. Many receive a left ventricular assist device, or LVAD, a surgically implanted, battery-operated device that helps the heart circulate blood. For some people with advanced heart failure, an LVAD buys time before a heart transplant. Others get the device for longer-term therapy.

Certain Groups Lest Likely to Receive LVADs

People who live in low-income ZIP codes, are black or Hispanic or are uninsured or covered by Medicaid are less likely to get the devices, according to a study presented earlier this year at the AHA’s Quality of Care and Outcomes Research Scientific Sessions. Past research also has shown women, who make up about one-third of advanced heart failure patients, receive less advanced therapy than men, including LVADs.

But for the new study, researchers wanted to see if LVAD gender disparity still occurs in the age of the latest generation of LVADs, which have gotten smaller, more durable and more popular.

Researchers looked at data from 29,934 hospitalizations from 2004 to 2016 in which people received LVADs. They found that while the devices were used more, women continued to represent a smaller proportion of LVAD recipients than men. In 2004, women made up about 26% of the those who got LVADs, but that shrunk to roughly 22% in 2016.

Decreased Death Rates for Men and Women

The study, which called LVADs a “potentially life-saving therapy,” also showed a significant decrease in death rates in hospitals for men and women who received the newer-generation devices.

Dr. Aditya Joshi, the study’s lead author, said it is possible doctors are implanting fewer LVADs in women based on outdated statistics that showed women had higher death rates than men after receiving older-generation LVADs. He called for new and current epidemiologic studies to break down the occurrence of advanced heart failure by sex.

“Now that we’re in an era with more durable and much smaller devices, the mortality difference between men and women has actually disappeared,” Joshi said. “We have to be more cognizant of the implicit bias that makes us choose different therapies for men and women.”

Calls for Further Research

Joshi, a cardiology fellow with the Mount Sinai Health System in New York, called for future in-depth research to confirm the findings.

Dr. Eileen Hsich, who was not involved in the study, said the research was limited by a lack of data on which patients were eligible for an LVAD and how many patients were offered the devices. She’d like future research also to focus on survival rates for LVAD patients versus heart transplant patients.

But she praised the work “for showing that with improvement in technology, there’s also improvement in survival.”

“We should all be excited about the results, which show that whether you’re a man or a woman, these new devices are very effective at keeping people alive, and their complications rates are low,” said Hsich, a cardiologist at the Kauffman Center for Heart Failure at the Cleveland Clinic.

Both men and women should learn more about LVADs and talk to their doctors about them as early as possible, she said.

“Education empowers patients. We need to open the conversation and prevent the fear factor so people can speak for themselves and advocate for better care,” Hsich said.

If you have questions or comments about this story, please email [email protected]

By American Heart Association
The American Heart Association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. Founded by six cardiologists in 1924, our organization now includes more than 22.5 million volunteers and supporters. We fund innovative research, fight for stronger public health policies, and provide critical tools and information to save and improve lives. Our nationwide organization includes 156 local offices and more than 3,000 employees. We moved our national headquarters from New York to Dallas in 1975 to be more centrally located. The American Stroke Association was created as a division in 1997 to bring together the organization’s stroke-related activities.

Next Avenue Editors Also Recommend:

Next Avenue brings you stories that are inspiring and change lives. We know that because we hear it from our readers every single day. One reader says,

"Every time I read a post, I feel like I'm able to take a single, clear lesson away from it, which is why I think it's so great."

Your generous donation will help us continue to bring you the information you care about. Every dollar donated allows us to remain a free and accessible public service. What story will you help make possible?